Salavati, Ali
Duan, Fenghai
Snyder, Bradley S.
Wei, Bo
Houshmand, Sina
Khiewvan, Benjapa
Opanowski, Adam
Simone, Charles B. II
Siegel, Barry A.
Machtay, Mitchell
Alavi, Abass
Article History
Received: 9 March 2017
Accepted: 5 June 2017
First Online: 8 July 2017
Compliance with ethical standards
:
: The ACRIN 6668/RTOG 0235 Trial receives funding from the National Cancer Institute through the grants U01 CA079778 and UO1 CA080098.
: None.
: Patients consented to the original prospective study, which was approved by the local institutional review board of each participating institution.